Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Catalyst Receives Pfizer Milestone in Hemostasis Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Catalyst Receives Pfizer Milestone in Hemostasis Pact

Catalyst Biosciences, Inc. has received a $4.0 million milestone payment from Pfizer under their collaboration agreement for the development of recombinant human Factor VIIa variants for the treatment of hemophilia and other bleeding disorders.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Catalyst Biosciences, Inc. has received a $4.0 million milestone payment from Pfizer under their collaboration agreement for the development of recombinant human Factor VIIa variants for the treatment of hemophilia and other bleeding disorders.

“We are very encouraged by the progress made to date in our Factor VIIa program, the most advanced program within Catalyst’s hemostasis franchise,” said Nassim Usman, Ph.D., Catalyst’s chief executive officer.”In addition to our work with Pfizer, Catalyst has independently achieved significant progress in engineering highly differentiated recombinant human Factor IX and Xa variants for acute and prophylactic treatment of bleeding disorders, including both hemophilia and non-hemophilia indications.Catalyst expects to expand and strengthen this pipeline of novel engineered proteases in the coming year.”

Total payments under the collaboration, which began in June 2009, could exceed $500 million, exclusive of royalty payments.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters